Addition of Daratumumab to First-Line Therapy of Newly Diagnosed Multiple Myeloma in Patients Eligible for Autologous Stem Cell Transplantation: A Single-Center Real-Life Experience
Mediterr J Hematol Infect Dis
.
2025 May 1;17(1):e2025040.
doi: 10.4084/MJHID.2025.040.
eCollection 2025.
Authors
Edoardo Olivari
1
2
,
Laura Paris
2
,
Paola Stefanoni
2
,
Chiara Pavoni
2
,
Alessandro Rambaldi
2
3
,
Monica Galli
2
Affiliations
1
University of Milan, Italy.
2
Department of Oncology and Hematology, ASST Papa Giovanni XXIII, Bergamo, Italy.
3
Department of Oncology and Hematology, University of Milan, Italy.
PMID:
40375903
PMCID:
PMC12081041
DOI:
10.4084/MJHID.2025.040
No abstract available
Keywords:
Autologous stem cell transplantation; Daratumumab; First-line therapy.